Assessment of neuropharmacological effects of ethanolic leaf extract of Pergularia daemia in migraine induced rat

Authors

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20263786

Keywords:

Pergularia daemia, Migraine, Nitroglycerin, Nitric oxide, Sumatriptan, Hippocampus

Abstract

Background: Migraine is a common neurological disorder. Pergularia daemia has reported anti-inflammatory and analgesic properties. We evaluated the neuropharmacological effects of its ethanolic leaf extract (EEPD) in nitroglycerin (NTG)-induced migraine in rats.

Methods: Leaves were extracted with ethanol (Soxhlet), screened phytochemically and analysed by GC-MS. Thirty male Wistar rats formed five groups: normal control; disease control (NTG 10 mg/kg I.P., days 1, 4, 7, 10, 13); sumatriptan 1 mg/kg I.P.; and EEPD 200 or 400 mg/kg P.O. for 14 days plus NTG. Migraine-like behaviour was scored (maximum 16), brain nitrite was estimated with Griess reagent, and hippocampal histology was examined. Scores were analysed by ANOVA with Dunnett's test.

Results: Yield was 28.78% w/w. Alkaloids, flavonoids, phenolics, tannins, steroids, carbohydrates and anthraquinone glycosides were detected; GC-MS tentatively identified 15 compounds, chiefly 3-O-acetyl-6-methoxy-cycloartenol (38.3% of area). The behavioural score was 9.40±0.24 in disease control versus 2.40±0.24 in normal control (p<0.0001), and 3.60±0.40 with sumatriptan, 2.80±0.49 and 2.60±0.24 with EEPD 200 and 400 mg/kg (all p<0.0001 versus disease control). Brain nitrite fell by 61% (sumatriptan), 26% and 29% (EEPD 200 and 400 mg/kg), although most values exceeded the calibration range and are qualitative. Disease-control hippocampus showed neuronal loss and degeneration; treated groups appeared normal.

Conclusions: EEPD attenuated NTG-induced behavioural changes, brain nitrite elevation and hippocampal alterations in rats, supporting further mechanistic evaluation as an anti-migraine candidate.

Metrics

Metrics Loading ...

References

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211. DOI: https://doi.org/10.1177/0333102417738202

GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019. Lancet. 2020;396(10258):1204-1222.

Vetvik KG. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16(1):76-87. DOI: https://doi.org/10.1016/S1474-4422(16)30293-9

Lipton RB. Migraine: epidemiology, impact, and risk factors for progression. Headache. 2005;45(Suppl 1):S3-S13. DOI: https://doi.org/10.1111/j.1526-4610.2005.4501001.x

Buse DC. Migraine progression: a systematic review. Headache. 2019;59(3):306-338. DOI: https://doi.org/10.1111/head.13459

Goadsby PJ. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97(2):553-622. DOI: https://doi.org/10.1152/physrev.00034.2015

Edvinsson L. The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine. Headache. 2017;57(Suppl 2):47-55. DOI: https://doi.org/10.1111/head.13081

Charles A. Cortical spreading depression and migraine. Nat Rev Neurol. 2013;9(11):637-644. DOI: https://doi.org/10.1038/nrneurol.2013.192

Ashina M. Migraine. N Engl J Med. 2020;383(19):1866-1876. DOI: https://doi.org/10.1056/NEJMra1915327

Gormley P, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48(8):856-866. DOI: https://doi.org/10.1038/ng.3598

Pietrobon D. Pathophysiology of migraine. Annu Rev Physiol. 2013;75:365-391. DOI: https://doi.org/10.1146/annurev-physiol-030212-183717

Russo AF. Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol. 2015;55:533-552. DOI: https://doi.org/10.1146/annurev-pharmtox-010814-124701

Oshinsky ML. Episodic dural stimulation in awake rats: a model for recurrent headache. Headache. 2007;47(7):1026-1036. DOI: https://doi.org/10.1111/j.1526-4610.2007.00871.x

Tassorelli C, Joseph SA. Nitroglycerin-induced Fos expression in the trigeminal system: an experimental model of migraine. Prog Brain Res. 1995.

Togha M, Razeghi Jahromi S, Ghorbani Z, Seifishahpar M, Sadeghi R. An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study. BMC Neurol. 2019;19:323. DOI: https://doi.org/10.1186/s12883-019-1555-4

Ulutas C, Bayir BRH, Cetinkaya Y, Guler EM, Agircan D, Ozkan BN. Migraine and neuroinflammation: correlation of adipokines and cytokines with clinical features. BMC Neurol. 2025;25(1):338. DOI: https://doi.org/10.1186/s12883-025-04319-w

Benemei S. The TRPA1 channel in migraine mechanism and treatment. Br J Pharmacol. 2014;171(10):2552-2567. DOI: https://doi.org/10.1111/bph.12512

Strassman AM. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 1996;384(6609):560-564. DOI: https://doi.org/10.1038/384560a0

Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. Nirali Prakashan, Pune.

Downloads

Published

2026-10-26

How to Cite

Abinaya, R., Charumathi, V., Kalaivani, B., Lokeshwari, S., & Sandhiya, A. (2026). Assessment of neuropharmacological effects of ethanolic leaf extract of Pergularia daemia in migraine induced rat. International Journal of Basic & Clinical Pharmacology, 15(6), 1326–1332. https://doi.org/10.18203/2319-2003.ijbcp20263786

Issue

Section

Original Research Articles